Neuroleptic-induced emesis: a new indication for clozapine?
Bustillo
J R
JR
Department of Psychiatry, Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, USA.
Buchanan
R W
RW
D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003024:Clozapine / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004409:Dyskinesia, Drug-Induced / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D008297:Male; D009460:Neurologic Examination / Q000187:drug effects; D012559:Schizophrenia / Q000175:diagnosis / Q000188:drug therapy*; D012565:Schizophrenic Psychology; D014839:Vomiting / Q000139:chemically induced* / Q000517:prevention & control
D014150:Antipsychotic Agents; D003024:Clozapine